C07C 327/44
To carbon atoms of an unsaturated carbon skeleton
Official title: to carbon atoms of an unsaturated carbon skeleton
C07C327/44 (To carbon atoms of an unsaturated carbon skeleton) appears on 93 US grants and 54 published applications in this corpus.
Search patents in C07C- Granted patents
- 93
- Published applications
- 54
- Assignees
- 54
- Inventors
- 196
- Latest grant
- 26 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 6 | 0 |
| 1994 | 5 | 0 |
| 1995 | 6 | 0 |
| 1996 | 4 | 0 |
| 1997 | 7 | 0 |
| 1998 | 9 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 7 | 2 |
| 2002 | 2 | 4 |
| 2003 | 6 | 8 |
| 2004 | 3 | 8 |
| 2005 | 2 | 2 |
| 2006 | 3 | 2 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 1 |
| 2010 | 0 | 2 |
| 2011 | 2 | 2 |
| 2012 | 0 | 0 |
| 2013 | 1 | 4 |
| 2014 | 2 | 0 |
| 2015 | 1 | 6 |
| 2016 | 5 | 3 |
| 2017 | 4 | 1 |
| 2018 | 1 | 2 |
| 2019 | 3 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 3 |
By publication year. Applications have been published since 2001.
Recent patents
- Functionally modified polypeptides and radiobiosynthesis26 Mar 2024US 11,939,617 B2Ikaria, Inc.
- Functionally modified polypeptides and radiobiosynthesis4 Jan 2022US 11,214,820 B2Ikaria, Inc.
- 2-cyano-3-cyclopropyl-3-hydroxy-N-aryl-thioacrylamide derivatives12 Nov 2019US 10,472,324 B2Algiax Pharmaceuticals GmbH
- Processes for converting carboxamides to thiocarboxamides17 Sep 2019US 10,414,723 B2Vertellus Holdings LLC
- Thioamides and amides for controlling animal pests20 Aug 2019US 10,385,012 B2BASF SE
- Isolated trans isomer of 3-(2-bromo-3,4-dihydroxy-phenyl)-n-(3,4,5-trihydroxy-benzyl)-thioacrylamide26 Dec 2024US 2024/0425452 A1Tyrnovo Ltd.
- Funtionally modified polypeptides and radiobiosynthesis5 Sep 2024US 2024/0294964 A1Ikaria, Inc.
- Combinations of irs/stat3 dual modulators and anti pd-1/pd-l1 antibodies for treating cancer29 Feb 2024US 2024/0067604 A1Tyrnovo Ltd.
- Functionally modified polypeptides and radiobiosynthesis19 Oct 2023US 2023/0332199 A1Ikaria, Inc.
- Thioamide-containing compositions and methods of use thereof13 Jan 2022US 2022/0009883 A1Noria Therapeutics, Inc.
Most cited
By later US patents
- Methods and compositions for inhibiting cell proliferative disorders109US 5,789,427 ASugen, Inc. · 1998
- FLK-1 is a receptor for vascular endothelial growth factor90US 5,851,999 AMax-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V. · 1998
- Methods and compositions for inhibiting cell proliferative disorders85US 5,773,476 ASugen, Inc. · 1998
- Quinazoline compounds and compositions thereof for the treatment of disease84US 5,792,771 ASugen, Inc. · 1998
- 2-oxindole compounds which are useful as tyrosine kinase inhibitors72US 5,374,652 AFarmitalia Carlo Erba S r l · 1994